Related Experiment Video
Updated: Mar 25, 2026
11:29
HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
11.7K
Leptin and its receptor in hematologic malignancies.
1Department of Hematology, Shandong Provincial Hospital, Shandong UniversityJinan 250021, Shandong, China; Department of Hematology, Tai'an Central HospitalTai'an 271000, Shandong, China.
International Journal of Clinical and Experimental Medicine
|February 18, 2016
Summary
Leptin, a cytokine involved in metabolism and blood cell development, is linked to hematologic malignancies. Its levels and receptor expression correlate with disease progression and patient characteristics, suggesting a role in cancer.
Area of Science:
- Endocrinology
- Hematology
- Oncology
Background:
- Leptin, an adipocyte-derived cytokine, regulates metabolism and hematopoiesis.
- Altered leptin levels are observed in hematologic malignancies, correlating with clinical factors like BMI and blast cell percentage.
- Leptin receptor is expressed on various hematopoietic cells, including those in leukemia and lymphoma patients.
Purpose of the Study:
- To review the expression of leptin and its receptor in hematologic malignancies.
- To explore the correlation between leptin signaling and clinical characteristics, treatment, and prognosis.
- To elucidate the role of leptin in the occurrence, progression, and prognosis of myeloid and lymphoid neoplasms.
Main Methods:
- Review of existing literature on leptin/leptin receptor expression in hematologic malignancies.
- Analysis of correlations between leptin levels and clinical parameters (BMI, gender, blast percentage).
- Examination of leptin signaling pathways (JAK-STAT, MAPK/ERK, PI3K) in malignant cells.
Main Results:
- Leptin concentrations fluctuate with disease progression and remission.
- Leptin receptor is present on malignant hematopoietic cells, including those in leukemia and lymphoma.
- Leptin signaling pathways promote proliferation, cytokine secretion, and inhibit apoptosis in cancer cells.
Conclusions:
- Leptin signaling plays a potential role in the development, progression, and outcome of hematologic malignancies.
- Understanding leptin's role may offer new therapeutic targets for myeloid and lymphoid neoplasms.
- Further research is warranted to fully elucidate leptin's impact on hematologic cancers.
Related Concept Videos
01:21Lineage Commitment
4.6K
Commitment is the process whereby stem cells:
4.6K
01:15Receptor Downregulation in MVBs
3.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
3.0K
01:28Role of Hematopoietic Growth Factors
4.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
4.3K
03:18Non-LTR Retrotransposons
14.0K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
14.0K
01:20The JAK-STAT Signaling Pathway
13.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.8K
01:28Insulin: The Receptor and Signaling Pathways
5.9K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.9K